Global New Medical Biomaterials Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 New Medical Biomaterials Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global New Medical Biomaterials Market Size Growth Rate by Product
  • 1.4.2 Metallic Material
  • 1.4.3 Bio-ceramic
  • 1.4.4 Polymer Materials
  • 1.4.5 Composites
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global New Medical Biomaterials Market Size Growth Rate by End User
  • 1.5.2 Packaging
  • 1.5.3 Transplant components
  • 1.5.4 Dental products
  • 1.5.5 Catheters
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global New Medical Biomaterials Market Size
  • 2.1.1 Global New Medical Biomaterials Revenue 2014-2025
  • 2.1.2 Global New Medical Biomaterials Sales 2014-2025
• 2.2 New Medical Biomaterials Growth Rate by Regions
  • 2.2.1 Global New Medical Biomaterials Sales by Regions
  • 2.2.2 Global New Medical Biomaterials Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 New Medical Biomaterials Sales by Manufacturers
  • 3.1.1 New Medical Biomaterials Sales by Manufacturers
  • 3.1.2 New Medical Biomaterials Sales Market Share by Manufacturers
  • 3.1.3 Global New Medical Biomaterials Market Concentration Ratio (CR5 and HHI)
• 3.2 New Medical Biomaterials Revenue by Manufacturers
  • 3.2.1 New Medical Biomaterials Revenue by Manufacturers (2014-2019)
  • 3.2.2 New Medical Biomaterials Revenue Share by Manufacturers (2014-2019)
• 3.3 New Medical Biomaterials Price by Manufacturers
• 3.4 New Medical Biomaterials Manufacturing Base Distribution, Product Types
  • 3.4.1 New Medical Biomaterials Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers New Medical Biomaterials Product Type
  • 3.4.3 Date of International Manufacturers Enter into New Medical Biomaterials Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global New Medical Biomaterials Sales by Product
• 4.2 Global New Medical Biomaterials Revenue by Product
• 4.3 New Medical Biomaterials Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global New Medical Biomaterials Breakdown Data by End User

6 North America

• 6.1 North America New Medical Biomaterials by Countries
  • 6.1.1 North America New Medical Biomaterials Sales by Countries
  • 6.1.2 North America New Medical Biomaterials Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America New Medical Biomaterials by Product
• 6.3 North America New Medical Biomaterials by End User

7 Europe

• 7.1 Europe New Medical Biomaterials by Countries
  • 7.1.1 Europe New Medical Biomaterials Sales by Countries
  • 7.1.2 Europe New Medical Biomaterials Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe New Medical Biomaterials by Product
• 7.3 Europe New Medical Biomaterials by End User

8 Asia Pacific

• 8.1 Asia Pacific New Medical Biomaterials by Countries
  • 8.1.1 Asia Pacific New Medical Biomaterials Sales by Countries
  • 8.1.2 Asia Pacific New Medical Biomaterials Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific New Medical Biomaterials by Product
• 8.3 Asia Pacific New Medical Biomaterials by End User

9 Central & South America

• 9.1 Central & South America New Medical Biomaterials by Countries
  • 9.1.1 Central & South America New Medical Biomaterials Sales by Countries
  • 9.1.2 Central & South America New Medical Biomaterials Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America New Medical Biomaterials by Product
• 9.3 Central & South America New Medical Biomaterials by End User

10 Middle East and Africa

• 10.1 Middle East and Africa New Medical Biomaterials by Countries
  • 10.1.1 Middle East and Africa New Medical Biomaterials Sales by Countries
  • 10.1.2 Middle East and Africa New Medical Biomaterials Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa New Medical Biomaterials by Product
• 10.3 Middle East and Africa New Medical Biomaterials by End User

11 Company Profiles

• 11.1 Invibio
  • 11.1.1 Invibio Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Invibio New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Invibio New Medical Biomaterials Products Offered
  • 11.1.5 Invibio Recent Development
• 11.2 STR
  • 11.2.1 STR Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 STR New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 STR New Medical Biomaterials Products Offered
  • 11.2.5 STR Recent Development
• 11.3 Avitus
  • 11.3.1 Avitus Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Avitus New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Avitus New Medical Biomaterials Products Offered
  • 11.3.5 Avitus Recent Development
• 11.4 Sagemax
  • 11.4.1 Sagemax Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sagemax New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sagemax New Medical Biomaterials Products Offered
  • 11.4.5 Sagemax Recent Development
• 11.5 Stratasys
  • 11.5.1 Stratasys Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Stratasys New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Stratasys New Medical Biomaterials Products Offered
  • 11.5.5 Stratasys Recent Development
• 11.6 Formlab
  • 11.6.1 Formlab Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Formlab New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Formlab New Medical Biomaterials Products Offered
  • 11.6.5 Formlab Recent Development
• 11.7 TeraPore Technologies
  • 11.7.1 TeraPore Technologies Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 TeraPore Technologies New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 TeraPore Technologies New Medical Biomaterials Products Offered
  • 11.7.5 TeraPore Technologies Recent Development
• 11.8 NanoH2O (LG)
  • 11.8.1 NanoH2O (LG) Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 NanoH2O (LG) New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 NanoH2O (LG) New Medical Biomaterials Products Offered
  • 11.8.5 NanoH2O (LG) Recent Development
• 11.9 Secant Medical
  • 11.9.1 Secant Medical Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Secant Medical New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Secant Medical New Medical Biomaterials Products Offered
  • 11.9.5 Secant Medical Recent Development
• 11.10 Covalent-coating
  • 11.10.1 Covalent-coating Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Covalent-coating New Medical Biomaterials Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Covalent-coating New Medical Biomaterials Products Offered
  • 11.10.5 Covalent-coating Recent Development
• 11.11 Nasseo
• 11.12 TriboFilm
• 11.13 ACS material
• 11.14 Palmaz Scientific

12 Future Forecast

• 12.1 New Medical Biomaterials Market Forecast by Regions
  • 12.1.1 Global New Medical Biomaterials Sales Forecast by Regions 2019-2025
  • 12.1.2 Global New Medical Biomaterials Revenue Forecast by Regions 2019-2025
• 12.2 New Medical Biomaterials Market Forecast by Product
  • 12.2.1 Global New Medical Biomaterials Sales Forecast by Product 2019-2025
  • 12.2.2 Global New Medical Biomaterials Revenue Forecast by Product 2019-2025
• 12.3 New Medical Biomaterials Market Forecast by End User
• 12.4 North America New Medical Biomaterials Forecast
• 12.5 Europe New Medical Biomaterials Forecast
• 12.6 Asia Pacific New Medical Biomaterials Forecast
• 12.7 Central & South America New Medical Biomaterials Forecast
• 12.8 Middle East and Africa New Medical Biomaterials Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 New Medical Biomaterials Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details